New insights into septal anterior wall motion velocities at end-systole in normal and hypertrophied left ventricles.

AIMS: It was two-fold (1) to define tissue Doppler echocardiographic characteristics of the end-systolic septal anterior motion: passive due to heart translation, or active motion free of translational effects, substantiated by a myocardial velocity gradient. (2) to specify the temporal features of this septal anterior motion on normal and hypertrophied left ventricles since it occurs while the posterior wall contracts during late ejection. METHODS AND RESULTS: Myocardial velocity gradient was calculated during the anterior motion in simultaneously colour M-mode imaged septal and posterior walls of 21 controls (49+/-12 years) and 17 patients (49+/-13 years) with left ventricle hypertrophy. Timings of septal motion were compared with flow and posterior wall motion. In controls, septal anterior motion started prior to, and overlapped the end of subaortic flow and that of the posterior wall anterior motion. Myocardial velocity gradient was found, exceeding that at the posterior wall (2.5+/-1.6 vs 0.9+/-0.5s(-1), P=0.001). In patients, septal myocardial velocity gradient was lower than in controls (1.2+/-1.04 s(-1)P=0.006). The anterior motion had a longer duration than in controls (75+/-37 vs 50+/-17ms, P=0.003). Myocardial velocity gradient and duration were correlated with septal thickness (P=<0.01). CONCLUSIONS: The septal anterior motion was active. Patients showed a decreased myocardial velocity gradient, while wall asynchrony increased. Unusual higher septal than posterior wall systolic velocities at tissue Doppler echocardiography may suggest a relaxation pattern, in spite of its end-systolic onset.

Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.

Treatment with beta blockers results in improvement in functional status, and reduces mortality in patients with heart failure. A number of differences in the results noted could be due to additional properties of the specific beta blockers studied: absence of cardioselectivity, and existence of a vasodilator effect and of an associated antioxidant effect. We studied the effects of celiprolol, a cardioselective beta blocker with a stimulant effect on beta2 receptors. One hundred thirty-two patients presenting with chronic heart failure of various etiologies, with an ejection fraction of <40% and New York Heart Association cardiac functional status grades II and III were included in a randomized, double-blind, placebo-controlled study. The maximum dose of celiprolol (100 mg) was attained after 1 month. The study lasted 1 year. The primary evaluation criterion was functional class as evaluated using the Goldman questionnaire. There was no difference in efficacy between the 2 treatment groups in terms of functional class (p = 0.56). With regard to the secondary evaluation criteria, an improvement in DiBianco functional score was seen with celiprolol (p = 0.03), as well as a significant reduction in heart rate (p = 0.01). Ejection fraction increased in both groups (p = 0.15). There was no difference regarding improvement in left ventricular volume as determined at echocardiography or in exercise capacity. The safety profile of celiprolol was excellent. There was no difference in terms of cardiovascular mortality (2 receiving celiprolol vs 4 placebo), onset of arrhythmias (2 receiving celiprolol vs 3 placebo), worsening of heart failure (26 receiving celiprolol vs 23 placebo), or noncardiovascular adverse events (9 receiving celiprolol vs 14 placebo). The absence of a significant efficacy of celiprolol, a beta blocker with vasodilator properties, but exerting stimulation of beta2 receptors, suggests an unfavorable role of this latter property in heart failure. However, the safety profile of celiprolol was excellent. This beta blocker may consequently be used for its other indications, hypertension and angina, in patients presenting with altered cardiac function.

[Diagnostic value of electrocardiography using dobutamine in coronary artery disease]. / Valeur diagnostique de l'électrocardiographie sous dobutamine dans l'insuffisance coronaire.

OBJECTIVES: Assess the sensitivity and specificity of electrocardiograms performed during dopamine perfusion to detect coronary artery stenosis. PATIENTS AND METHODS: One hundred three coronary artery disease patients with a coronarography were studied; 23 coronarographies were normal, 59 patients were taking a beta blocker. An exercise test was also performed in 54 cases. A dobutamine perfusion was given at increasing dosage up to 50 micrograms/kg/min, in combination with intravenous atropine if needed to obtain a heart rate close to the theoretical maximum. RESULTS: The ST segment could not be analyzed reliably in 12 patients. There was an ST depression in 32 cases, an ST elevation in 20 and an isoelectric ST in 39. The sensitivity of a positive test to detect stenosis was 67% and specificity was 83%. Test sensitivity increases with increasing number of stenotic lesions. There were no false positives in patients with an ST elevation. Results were not related to gender nor beta blocker treatment. The exercise tests were globally comparable but poorer in patients taking beta blockers. There were no notable adverse effects. CONCLUSION: Dobutamine perfusion electrocardiogram is a simple well-tolerated exploration method for the diagnosis of coronary artery disease applicable in all patients. Its diagnostic value is similar to that of the exercise test and better in patients taking beta blockers. Specificity is excellent and sensitivity is acceptable, particularly in patients with mulitvessel disease.

Concordance between dobutamine Doppler tissue imaging echocardiography and rest reinjection thallium-201 tomography in dysfunctional hypoperfused myocardium.

OBJECTIVE: To evaluate the efficiency of the new technique colour Doppler tissue imaging (DTI) by studying the concordance between dobutamine DTI, standard grey scale echocardiography (SE), and rest-reinjection TI-201 tomography (TI) in dysfunctional myocardium. PATIENTS: 23 patients with chronic wall motion abnormalities and proven coronary artery disease (> 70% diameter stenosis of at least one major coronary artery at angiogram). METHODS: The contractile reserve and the resting perfusion characteristics of dysfunctional myocardial segments were assessed with low dose dobutamine SE and/or DTI (2.5 up to 20 gamma/kg/min) and TI on a semiquantitative basis. The DTI or SE data were separately compared with TI, on the basis of a 13 segment ventricular model. The resulting score of combined DTI and SE was also compared with TI. Finally the results obtained from DTI were compared with SE. RESULTS: A total of 142 severely hypokinetic or akinetic segments were visualised. The viability study was feasible in 127 (89%) and 121 (85%) segments with DTI and SE, respectively. TI detected viability more frequently than DTI (84 v 61, p < 0.001) and SE (80 v 50, p < 0.001). However, as many viable segments were detected with combined DTI and SE as with TI (78 v 84, NS). The kappa values between TI and SE, DTI or combined SE and DTI were 0.38, 0.45, and 0.57, respectively, and increased to 0.52 and 0.76, respectively, for SE and DTI versus TI when mid-anterior and mid-inferior segments only were considered. The kappa value between SE and DTI was 0.34. CONCLUSIONS: DTI is a helpful adjunct to SE, when using low dose dobutamine. This combination revealed as many viable segments as TI and showed a better agreement than DTI or SE alone for the assessment of myocardial viable segments evidenced by TI.

Comparison of 2 myocardial velocity gradient assessment methods during dobutamine infusion with Doppler myocardial imaging.

Myocardial velocity gradient (MVG) has been shown to be the best quantitative parameter for the detection of ischemic myocardium during dobutamine infusion with the use of Doppler myocardial imaging. MVG has been previously assessed by velocity measurements across the thickness of the myocardium at the time of visually selected maximal color brightness (thickness-velocity plot method). We hypothesized that MVG could be assessed by velocity measurements throughout the cardiac cycle in the subendocardium parallel to the endocardial boundary to the left ventricular cavity and in the subepicardium parallel to the epicardial boundary (time-velocity plot method). This study was designed to compare MVG obtained from the thickness-velocity plot method and from the time-velocity plot method in quantifying dobutamine-induced changes in myocardial wall motion in 8 phases of the cardiac cycle on color M-mode Doppler myocardial imaging recordings of the left ventricular posterior wall performed in 8 conscious dogs at baseline and at steady state during dobutamine infusion (10 microg/kg per minute). For both methods, MVG was considered present if its mean value was significantly different from zero and if endocardial and epicardial velocities were significantly different. There was close agreement between the 2 methods. MVG was present during the preejection period, systole, rapid ventricular filling, and atrial contraction. Dobutamine induced a significant increase in MVG during the preejection period (from 2.64 +/- 0.83 to 4.05 +/- 0.81 seconds-1 ), systole (from 2.14 +/- 0.59 to 6.08 +/- 2.20 seconds-1 in early systole, from 1.90 +/- 1.06 to 5.31 +/- 2.95 seconds-1 in mid systole, from 1.37 +/- 0.57 to 2.44 +/- 0.53 seconds-1 in end systole), and rapid ventricular filling (from 3.06 +/- 1.12 to 7.82 +/- 2.58 seconds-1 ), related to a greater rise in endocardial than in epicardial velocities. The time-velocity plot method showed that ejection and diastole were 11% and 28% decreased during dobutamine infusion, respectively, as heart rate was 31% increased. Thus according to our quantitative criteria, both MVG assessment procedures enabled objective interpretation of dobutamine effects on left ventricular wall motion. In addition, the time-velocity plot method provided automatic detection of peak velocity, timing, and duration of wall velocity changes over time.

[Doppler tissue imaging of pre-ejection left ventricular wall dynamics in normal subjects]. / Dynamique pariétale pré-éjectionnelle du ventricule gauche par imagerie doppler tissulaire. Description chez le sujet normal.

Pre-ejectional left ventricular wall motion has been demonstrated clinically by angiography. Intramyocardial wall velocities generated by cardiac contraction may be measured by Doppler tissue imaging. The aim of this study was to detect pre-ejectional wall motion and to analyse its sequencer. A long axis M Mode with simultaneous septal and posterior wall imaging was performed in 11 normal subjects (age 37 +/- 15 years) with velocity analysis between the electrocardiographic Q wave and the onset of ejection by digitised analysis between the electrocardiographic Q wave and the onset of ejection by digitised images with automatic velocity extraction (3.8 ms) along a horizontal subendocardial line. The total duration of the pre-ejectional periods in conventional and Doppler tissue imaging are compared. Oscillatory velocimetric appearances with alternate colours of adjacent bands in each wall and a mirror image between walls was observed. The mean and peak velocities of the first four bands were significantly different between the walls (p < 0.001) as were the absolute values between bands 2 (p < 0.02) and 3 (p < 0.006). The duration of band 2, related to motion mainly towards the center of the ventricular chamber exceeded that of the adjacent bands (septum p < 0.02, posterior wall p < 0.001). The correlation coefficient for total duration of the pre-ejectional period between Doppler tissue imaging and conventional Doppler was 0.83, p < 0.05 for the interventricular septum and 0.76, p < 0.04 for the posterior was. The authors conclude that regional pre-ejectional wall motion can be recorded. During isovolumic contraction, there is motion predominantly towards the center of the left ventricular chamber of the two walls, confirming previous angiographic findings. Its timing suggests that wall motion proceeds the increase in ventricular pressure.

[Contribution of doppler imaging of the myocardium to the study of cardiomyopathies]. / Apport de l'imagerie doppler du myocarde pour l'étude des cardiomyopathies.

Colour Doppler imaging (CDI) is a recent method of evaluation of cardiomyopathy based on intra-myocardial abnormalities. CDI provides quantitative assessment of myocardial wall motion both circumferential by studying the movements of the myocardium and longitudinal by studying the movements of the mitral annulus. The harmonious decrease in velocity between the endocardium and epicardium disappears in pathological conditions, showing disorganisation of wall motion within the myocardium. The decrease in the early diastolic transmural velocity gradient in patients with cardiomyopathy indicates diastolic dysfunction independent of the left ventricular systolic function. In addition, CDI is more sensitive than conventional Doppler echocardiography with grey scale because it enables earlier detection of changes induced by low-dose dobutamine, allowing distinction between trained athletes and patients with hypertrophic cardiomyopathy. The velocities of the mitral annulus help to prevent errors of interpretation of mitral blood flow as they are relatively independent on the left ventricular preload.

Pre-ejectional left ventricular wall motions studied on conscious dogs using Doppler myocardial imaging: relationships with indices of left ventricular function.

Duration of the pre-ejection period is a sensitive index of myocardial function. Our purpose was to document normal pre-ejectional left ventricular (LV) wall motions at rest and under dobutamine using Doppler myocardial imaging (DMI), and to correlate posterior wall velocities with indices of LV systolic function. M-mode recordings of both walls were imaged on eight conscious dogs chronically instrumented. Subendocardial pre-ejectional velocities were digitized and measured every 3.8 ms. DMI analysis consisted of sign recognition, velocity measurement, duration and timing from the Q wave of the electrocardiogram. Isovolumic contraction time (Ict) was represented by the time interval from onset to peak of the first derivative of LV pressure. Conventional Doppler labelling of velocity signs, positive toward and negative away from the transducer, was applied to the direction of encoded wall motions. For physiological understanding, wall motions of both walls were also labelled inward and outward with respect to the left ventricular cavity center. In each wall, PEP was shown as several colored strips, each strip representing the period of time that the wall was moving in one direction. Changes in velocity sign corresponding to changes in direction of motion were opposed in each wall (p < 0.001), featuring successive inward and outward wall motions. There was a markedly sustained inward motion during Ict. Its velocity amplitude increased with dobutamine. There was a positive correlation between velocities of the inward motion contemporaneous of Ict and ejection fraction (r = 0.72, p < 0.003). Values of Ict respectively drawn from DMI and from hemodynamics were also significantly correlated (r = 0.85, p < 0.007). Thus, the inward motion evidenced by DMI during Ict appears promising to assess myocardial function and effect of drugs.

Right and left isovolumic ventricular relaxation time intervals compared in patients by means of a single-pulsed Doppler method.

Right and left isovolumic ventricular relaxation time intervals measurements were obtained as follows: from the peak R wave on the electrocardiogram to either the mitral or the tricuspid pulsed Doppler flow trace onset minus the R to end-ejection zero flow crossing of the subaortic (left side) or pulmonary (right side) D flow trace time interval. A ratio was calculated as a percent difference duration between both isovolumic ventricular relaxation time intervals. The aim was to compare isovolumic ventricular relaxation time interval values in 42 healthy controls and to study the changes induced by heart diseases in 27 patients with (1) controlled hypertension without left ventricular hypertrophy, (2) hypertrophic cardiomyopathy, and (3) Cor pulmonale. Mean values of isovolumic ventricular relaxation time intervals significantly differed at paired and unpaired studies, with right isovolumic ventricular relaxation time intervals shorter than those of the left side in all groups (p < 0.001) except for patients with Cor pulmonale. Isovolumic ventricular relaxation time intervals did not correlate with heart rate and moderately correlated with left ventricular mass and age. No significant difference was found between healthy controls and patients with controlled hypertension. Significant changes were found in patients with hypertrophic cardiomyopathy and Cor pulmonale versus healthy controls for both isovolumic ventricular relaxation time intervals. However, significant changes in the ratio were only found in patients with Cor pulmonale (p < 0.005) because of abnormal similar values for both isovolumic ventricular relaxation time intervals. This Doppler method enabled, for the first time, serial comparison of isovolumic ventricular relaxation time intervals with a homologous method. Both isovolumic ventricular relaxation time intervals significantly lengthened with age and with left ventricular indexed mass, but their ratio remained insignificantly changed except for patients with Cor pulmonale. The concomitant right and left isovolumic ventricular relaxation time intervals lengthening in patients with hypertrophic cardiomyopathy and Cor pulmonale suggests interdependence of both ventricles through the septum. This makes recommendable systematic comparison of both sides. The calculation of a ratio, free from the effect of factors intervening on isovolumic ventricular relaxation time intervals, may, in addition, be of diagnostic help.

Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS).

BACKGROUND: To further evaluate the mechanism of beta-blocker-induced benefits in heart failure, the relationships between bisoprolol-induced hemodynamic effects and survival were studied during the Cardiac Insufficiency BIsoprolol Study (CIBIS). METHODS AND RESULTS: In 557 patients studied, bisoprolol significantly reduced heart rate (-16.3+/-15.3 versus -1.6+/-13.4 bpm, respectively; P<.001) compared with placebo at 2 months after inclusion in the study. Heart rate change over time had the highest predictive value for survival (P<.01). Left ventricular fractional shortening (LVFS) significantly increased in the bisoprolol group compared with the placebo group 5 months after inclusion (+0.04+/-0.06 versus -0.001+/-0.05, respectively; P<.001; n=160). LVFS change over time was also significantly correlated with further survival (P<.02 by Cox analysis). Using a nonparametric approach, we demonstrated a significant interaction between study treatment group and LVFS over time. Patients who demonstrated improvement of LVFS over time (82% and 51% of patients in the bisoprolol and the placebo groups, respectively; P<.02) were at lower risk, but the hazard did not further decrease with a further increase of fractional shortening, and there was no significant difference between study treatment groups. Finally, it could be demonstrated that each of the three factors (heart rate change over time, LVFS change over time, and bisoprolol treatment) made a specific contribution to mortality rate. CONCLUSIONS: Preservation of left ventricular function appears to play a key role in the bisoprolol-induced beneficial effects on prognosis in heart failure. Short-term beta-blocker-induced cardiac effects could provide a means to identify those patients who will experience improved survival over the long term.

Preejectional left ventricular wall motion in normal subjects using Doppler tissue imaging and correlation with ejection fraction.

Relations have been demonstrated between the preejection period (PEP) and indexes of left ventricular (LV) systolic function. Doppler tissue M-mode imaging has the capability to measure wall velocities and to display as colored strips within the walls velocity reversals representing changes in direction of wall motion. To document LV preejectional wall motions, this procedure was performed on 16 normal subjects with a twofold purpose: to measure septal and posterior preejectional intramyocardial velocities and durations and to correlate preejectional parameters with LV ejection fraction (LVEF). Parasternal M-mode images of simultaneously recorded walls were digitized. Subendocardial wall velocities were measured every 3.8 ms from the Q wave to the onset of ejection. Total duration measured from Doppler tissue and flow traces was compared in 10 subjects. PEP total duration did not differ between both walls or techniques. Several adjacent velocity reversals with mirror signs in opposite walls were substantiated by 2 to 5 colored strips. Colored strips corresponding to the same sign in each wall had a progressively damped velocity amplitude (septum 19 +/- 8, -21 +/- 10, 15 +/- 7, -8 +/- 5, 4 +/- 2 mm/s; posterior wall -13 +/- 16, 11 +/- 7, -8 +/- 5, 9 +/- 6, -2 mm/s). Peak velocity values of opposite signs significantly differed between both walls (p <0.0001). Absolute values differed only for colored strips 2 and 3 (p <0.009). Strip 2 featured a simultaneous early inward motion of both walls toward the LV cavity with significantly prolonged duration (p <0.0001). The only positive correlation with LVEF was found for peak velocities of strip 2 in the posterior wall (r = 0.71, p <0.006). Thus, the posterior wall and its inward motion velocities have potential for future clinical implications.

[Comparative effects of captopril and atenolol on lipid metabolism in hypertensive hypercholesterolemic patients treated with pravastatin. A multicenter controlled trial]. / Effets comparés du captopril et de l'aténolol sur le métabolisme lipidique chez des patients hypertendus hypercholestérolémiques traités par pravastatine. Essai multicentrique contrôlé.

OBJECTIVES: A randomized double-blind trial was conducted in hypertensive subjects with hypercholesterolemia treated with pravastatin in order to compare the effects of captopril and atenolol on lipid metabolism. METHODS: After a pre-inclusion period, 147 eligible subjects (64 men and 83 women, age range 32-74 years) were randomized into two groups and given, in a double-blind trial, either captopril (50 mg/d) or atenolol (50 mg/d) for 6 months. The controlled trial was followed by an open trial in 120 subjects for 6 more months. Laboratory tests for lipid metabolism were performed at inclusion and at 6 months. RESULTS: Control of blood pressure was satisfactory and similar in the two groups. Lipid tests were performed both in local and a centralized laboratory with good interlaboratory correlations. High density lipoprotein (HDL)-cholesterol remained unchanged in the captopril group declined slightly in the atenolol group. Total cholesterol increased moderately in both groups. Triglycerides increased somewhat in the captopril group and significantly more in the atenolol group. These results were maintained during the open trial. Most of the undesirable effects were benign and did not require treatment. CONCLUSION: The effects of captopril and of atenolol are not diminished in combination regimens with pravastatin. The antihypertensive efficacy was similar for the two treatments, but the effect on lipid metabolism was more favorable with captopril.

[Drug therapy of heart failure. What choice in 1996?]. / Les traitements medicamenteux de l'insuffisance cardiaque. Quel choix en 1996?

The mortality of heart failure remains high despite recent therapeutic progress. The objectives of treatment are to relieve symptoms, but also to improve survival. The secondary objectives are extension of the duration of effort, improvement of the ejection fraction, reduction of arrhythmias and neuroendocrine disturbances, although these criteria are not strictly related to the primary objectives. Diuretics should be used from the first symptoms, but their effect on survival has not been evaluated. Digitalis alkaloids, with no effect on survival, also improve functional signs, even in patients in sinus rhythm. All other positive inotropic agents increase mortality. Nitrates improve symptoms and, when associated with hydralazine, prolong survival. Amiodarone should be reserved to patients with dangerous arrhythmias. Angiotensin converting enzyme inhibitors have the best demonstrated effect on survival and must be used as first-line treatment. Their preventive effect on mortality is limited, except in post-infarction ventricular dysfunction. Beta-blockers, which appear very promising for the improvement of survival, functional signs and ejection fraction, are currently under evaluation. Their mechanisms of action and the choice of the most active drugs have yet to be determined.

[Prognostic factors of prosthetic valve endocarditis. Apropos of 122 cases]. / Facteurs pronostiques des endocardites sur prothèse valvulaire. A propos de 122 observations.

The prognostic factors of 122 patients suffering from prosthetic valve endocarditis between 1978 and 1992 were studied by univariate and multivariate analysis. The principal causative organisms were Staphylococcus aureus (33%), streptococci (20%), coagular-negative staphylococci (12%), enterococci (10%) and gram-negative bacilli (9%). The 4 month survival rate was 66% (42 deaths). The main predictive factor for death was infection with S. aureus (75% vs 15% with other organisms). In S. aureus infection, multivariate analysis identified the following predictive factors for death: a prothrombin ratio less than 30% (RR = 8.3), mediastinitis (RR = 4.9), cardiac failure (RR = 4.4) and septic shock (RR = 2.6). In cases of infection with other organisms, the following factors were predictive of death: a prothrombin ratio of less than 30% (RR = 32.26), renal failure (RR = 7.31) and cardiac failure (RR = 6.07). In patients with S. aureus infection, survival was better after than without surgery: 9/20 (45%) versus 0/20 (p < 0.001). In infection with other organisms, there was no difference in a survival after surgical (89%) or medical therapy (81%). Chronic endocarditis relapses over 1 to 5 years was observed in 9 cases. All patients were reoperated a total number of 18 times with 5 deaths. Very prolonged antibiotic therapy is recommended in these patients. The authors conclude that endocarditis not due to S. aureus and without complications may be treated medically. Rapid reoperation is necessary in all other cases.

Colour doppler valvar and subvalvar flow diameter imaging versus echo score in mitral stenosis: comparison with type of surgery.

OBJECTIVE: To compare the value of echo score with that of Doppler subvalvar flow broadening in deciding the type of mitral stenosis surgery. PATIENTS: 30 patients, mean age 47 years, with severe stenosis undergoing surgery were divided into two groups according to type of surgery: open heart commissurotomy (group 1, n = 12), or prosthesis (group 2, n = 18). A control group of 10 patients with prosthesis served as reference, representing mild stenosis without subvalvar connection. METHODS: For echo, the score proposed by Wilkins for cross sectional imaging was used. For Doppler, the flow diameters were measured in cm by an independent examiner from the long axis view in early diastole at two levels: (1) at the level of the stenosis (origin flow diameter), and (2) 1.5 cm downstream from the stenosis in the left ventricle (subvalvar flow diameter) with calculation of a Doppler ratio relating these two measurements, expressed as a percentage of broadening. Diagnostic value was compared for both procedures. RESULTS: There was no significant difference in age, mitral valve areas, or haemodynamics for the two groups. Mean values (SD) were: echo score: group 1, 9.83 (1.26) v group 2, 10.8 (8.1), NS; Doppler ratio %: group 1, 44 (24) v group 2, 12 (21) (P < 0.001); control group: 69 (15). The per cent diagnostic value for an open heart commissurotomy of respective cut off points was: Doppler ratio > 25% (range 71% to 87%); echo score < 10 (range 50% to 75%). CONCLUSIONS: The new Doppler ratio diagnostic value agreed better with surgical management, repair or prosthesis, in this study. Thus, it appears to better reflect the subvalvar involvement and changes in kinetics than the echo score alone. This easy Doppler method might become a routine examination for follow up of patients with open heart commissurotomy, to avoid performing repeated transoesophageal echocardiography.

[Prognostic value of exercise gamma-angiography in coronary insufficiency]. / Valeur pronostique de la gamma-angiographie d'effort dans l'insuffisance coronarienne.

The predictive value for cardiac events in stable coronary artery disease was analysed with resting and exercise radionuclide angiography and conventional exercise stress testing under medical therapy. The population comprised 93 men and 12 women, followed up for 1 to 8 years (mean 51 months). The patients were divided into two groups. Group I without cardiac events; Group II including spontaneous complications and myocardial revascularisations. The analysis was performed at 2 years and at the end of follow-up. At 2 years, 30 events (15 spontaneous complications, 15 revascularisations) were observed, and at the end of follow-up, there were 61 uncomplicated outcomes and 44 cardiac events (22 spontaneous complications, 22 revascularisations). Two independent prognostic factors distinguishing patients in Group I from those in Group II were identified at 2 years and at the end of the study: exercise EF and occurrence of exercise (on: chest pain on exercise) chest pain. Four parameters were significantly different between the two groups at 2 years: exercise EF, resting EF, difference between exercise-resting EF (all p < 0.005) and duration of exercise testing (p = 0.04). The 3 radionuclide parameters remained different between the 2 groups as well as chest pain on exercise stress testing (p = 0.03) throughout the study. The predictive value of these parameters depended on the type of cardiac event. The exercise EF was the best predictive factor of cardiac death. Pain and ST depression on exercise ECG were the best predictive factors for myocardial revascularisation. In 12 patients undergoing myocardial revascularisation, the clearest improvement was observed in exercise EF (p = 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision.

We carried out univariate and multivariate analysis of outcome among 122 patients with prosthetic valve endocarditis (PVE) admitted to our ICU between 1978 and 1992. The predominant pathogens were Staphylococcus aureus (33%), streptococci (20%), coagulase-negative staphylococci (12%), enterococci (10%), and Gram-negative bacilli (9%). At 4 months, overall survival was 66% (42 deaths). Staphylococcus aureus was the main predictor of death (75% vs 15% with other pathogens). In S aureus PVE, multivariate analysis identified the following predictors of death: prothrombin time < 30% (relative risk [RR]: 8.3), concomitant mediastinitis (RR: 4.9), heart failure (RR: 4.4), and septic shock (RR: 2.6). In PVE due to other pathogens, prothrombin time < 30% (RR: 32.26), renal failure (RR: 7.31), and heart failure (RR: 6.07) were associated with death. In S aureus PVE, survival was higher in patients who received medical-surgical therapy than in those who received medical therapy alone (9/20 [45%] vs 0/20) (p < 0.01). In PVE due to other pathogens, there was no difference in survival between patients who underwent prosthesis replacement (89%) and those who received only medical treatment (81%). Among the 65 patients who underwent heart surgery, the mortality rate and incidence of postoperative paravalvular leakage did not correlate with positive prosthesis cultures. We conclude that non-S aureus and uncomplicated PVE may be managed without valve replacement but that prompt surgical intervention should be required in all other situations.

Nicorandil safety in the long-term treatment of coronary heart disease.

The results of an open prospective study that evaluated the long-term clinical safety of nicorandil are presented. This study included 199 patients with severe chronic stable angina treated over a 1-year period. The most often reported adverse event was headache, which was responsible for most of the study withdrawals due to clinical intolerance (9.6%). When using a progressive titration scheme, this incidence was substantially reduced to 2.7%. As with other less frequent adverse events (dizziness, gastrointestinal disorders), headaches were reported as being mild to moderate in severity, were experienced during the first days of treatment, and, if treatment was maintained, usually resolved within a few days. The incidence of adverse events was not modified when nicorandil was given in combination with a beta-blocker, a calcium antagonist, or both agents. Cardiovascular safety was satisfactory and laboratory parameters were not altered. At the end of the study, 70% of patients were maintained on nicorandil. These results are in agreement with those reported from the nicorandil safety database, which gathered 1152 patients treated by nicorandil, including those of the present study. In comparative studies of nicorandil versus beta-blockers, calcium antagonists, or nitrates, the overall incidence of adverse events was no different between the two treatment groups, although the safety profile differed according to the drug category.(ABSTRACT TRUNCATED AT 250 WORDS)